Nuvothera, a Fort Worth, Texas-based biotech company, has reached agreement and has its revolutionary Prosoria Psoriasis Treatment System in select CVS HealthHUB Stores. Additionally, it soon will be available on CVS.com.

FORT WORTH, TX, April 25, 2022 /24-7PressRelease/ — Nuvothera, a Fort Worth, Texas-based biotech company, has reached agreement and has its revolutionary Prosoria Psoriasis Treatment System in select CVS HealthHUB Stores. Additionally, it soon will be available on CVS.com.

Prosoria is an effective, over-the-counter treatment with long-lasting results for a tough-to-treat skin condition. Formulated with maximum strength ingredients, botanicals and vitamins, Prosoria effectively relieves psoriasis symptoms and is safe for daily use. The formula is steroid-free, paraben-free, and fragrance-free.

The once-daily, 2-step treatment system includes a treatment gel developed to optimize the relief of psoriasis symptoms. It’s used with an exfoliating moisturizer made to rapidly remove scaling and flaking while intensively moisturizing the skin. The combination of these two products in a daily regimen makes the difference.

“We knew with the advanced pharmaceutical technology that we could make a better and more effective ‘over-the-counter’ treatment that was safe to use every day,” said Art Clapp, CEO of Nuvothera. “We are constantly seeking ways to improve our customers’ experience and satisfaction. With the proper approach, psoriasis symptoms can be well controlled.”

“Getting into retail drugstores is a game changer. This significant milestone enables us to quickly launch products and reach significantly more people with skin conditions. The drugstore channel is huge, and we’ve prepared for rapid growth.” Next year, Nuvothera expects to expand distribution into other major drugstores.

Prosoria already is available for purchase online at Prosoria.com and Amazon, and it is eligible for HSA and FSA reimbursement. Nuvothera will continue to sell online and expects to double sales during 2022, propelled by the launch of a new line of products to treat scalp psoriasis and seborrheic dermatitis.

There are approximately nine million people in the U.S. with psoriasis and 125 million worldwide. Dry, red, flaky patches of skin characterize the condition, which is an inherited inflammatory condition and is not contagious. Inflammatory conditions such as psoriasis tend to have flares, which are cycles of improvement and worsening. There is no cure for psoriasis, and it is a condition that can be difficult to manage and control. The National Psoriasis Foundation has recognized Prosoria as an effective treatment to help relieve symptoms of psoriasis.

Nuvothera uses pharmaceutical technology and advanced plant science to boost the effectiveness
of its healthcare products. It focuses on topical solutions for difficult-to-treat skin conditions such as psoriasis, eczema, warts, and nail fungus; it also has a turmeric-based pill to effectively relieve inflammation and joint pain.

Nuvothera was founded by seasoned dermatology pharmaceutical executives to develop novel products for difficult-to-treat skin conditions and chronic inflammatory diseases. It is a client of TechFW, a technology incubator/accelerator that helps companies get to market and grow.

CVS HealthHUB stores, including Minute Clinics, continue to expand into a community health destination designed to make healthcare more convenient, personalized, and affordable. For more information, contact [email protected].com or call 817-905-2784.

TechFW helps innovators launch and grow emerging technology companies, and operates programs– a non-seed accelerator, business incubator and angel investor network — that build, educate and support tech entrepreneurs and startups in an effort to take their proprietary innovations to market. For more information, contact Briana Wucinski, Marketing and Communications Manager — O: 817.984.9841 C: 682.300.1210

Nuvothera is a Fort Worth, TX-based biotech company formed by seasoned dermatology pharmaceutical executives with the mission of developing novel OTC products for difficult-to-treat skin conditions and chronic inflammatory diseases such as psoriasis. Nuvothera’s products incorporate natural botanical ingredients and use the latest in scientific knowledge and evidence-based research. Nuvothera’s products include Prosoria™, a topical daily psoriasis treatment system, and our Nuvothera Super-Micronized™ Turmeric Curcumin dietary supplement.


For the original version of this press release, please visit 24-7PressRelease.com here